SRF News, Corporate filings and Earnings/Conference Calls

29 Jul 2026

2598.40

0.25%

Earnings Call

SRF Ltd - 503806 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the Earnings Call held on 23rd July 2026

27 Jul 2026

2598.40

0.25%

Company Update

SRF Ltd - 503806 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) …

BSE India

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

24 Jul 2026

2598.40

0.25%

SRF Ltd.

Buy: SRF Ltd.

Target

ICICI Direct

SRF has revised its capex for the next-generation refrigerants (HFO) project to 2,285 crore (vs 1,100 crore earlier). This will take the company's total HFC capacity to 65000 TPA from the current 52000 TPA....

23 Jul 2026

2598.40

0.25%

Company Update

SRF Ltd - 503806 - Tax Deducted At Source (TDS) On Dividend

BSE India

Tax Deducted at Source (TDS) on Dividend

23 Jul 2026

2598.40

0.25%

Earnings Call

SRF Ltd - 503806 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Audio recording of the Earnings Call

23 Jul 2026

2598.40

0.25%

Company Update

SRF Ltd - 503806 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publications

SRF tanks 9% post June quarter results; board approves 250 cr capex

23 Jul 2026

2598.40

0.25%

Business Standard

SRF reported 76% YoY growth in Q1FY27 PAT. It is undertaking a series of smaller capital expenditure projects within the Specialty Chemicals business to enhance capacity and operational efficiencies.

23 Jul 2026

2598.40

0.25%

SRF Ltd. Results Earnings Call for Q1FY27

Conference Call with SRF Ltd. Management and Analysts on Q1FY27 Performance and Outlook. Listen to the full earnings transcript.

audio

23 Jul 2026

2598.40

0.25%

SRF: Q1FY27 Result Review

Buy: SRF Ltd.

Target

IDBI Capital

SRF delivered a strong performance in Q1FY27 propelled by robust growth in all the key business verticals. Revenue, EBITDA and PAT grew by 32%, 49% and 76% respectively. The Chemicals business registered a growth of 26% YoY and EBIT growth of 27% YoY led by strong Ref-Gas pricing as well as higher volumes across domestic and exports markets. In terms of Specialty Chemicals business positive demand trends have been seen in set of core products in volumes as well as prices. The recovery in the agrochemical segment is expected...

23 Jul 2026

2598.40

0.25%

Robust performance across all segments

Buy: SRF Ltd.

Target

Motilal Oswal

SRF delivered a strong performance in 1QFY27 as EBIT grew 61% YoY, led by a 27%/1.9x/1.5x YoY jump in EBIT of chemicals/technical textiles business (TTB)/ performance films and foil (PFF) businesses.

Is SRF Ltd. worth buying?

434 Votes:

Buy 74.42%

Sell 15.67%

Hold 9.91%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >